Strides Pharma Science informs about press release

19 Mar 2021 Evaluate

Strides Pharma Science has informed that it has attached Press Release on 19th March 2021 issued by Stelis Biopharma, the biopharmaceutical division of Strides titled ‘Stelis concludes US$ 195m Series B and Series C fund raise Significant interest from marquee long term investors’.

The above information is a part of company’s filings submitted to BSE.


Strides Pharma Scien Share Price

793.60 -2.60 (-0.33%)
27-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.30
Dr. Reddys Lab 1240.00
Cipla 1312.85
Zydus Lifesciences 893.45
Lupin 2147.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×